📊 Score Breakdown
Offering Ability
60
Cash Runway
0
Float Risk
45
Warrant Exposure
15
Convertible Debt—
🌦️ Dilution Forecast
🌥️
Advisory
Moderate dilution signals present
29%
📉 Score Deterioration
40%
• Score rose 20 points recently (worsening)
💰 Capital Raise
20%
• Active shelf registration ($35M, 19% of market cap)
🔄 Reverse Split
15%
• 52-week low $0.27 has breached $1
💹 Market Data
Market Cap$183.36M
Shares Outstanding63.23M
Float31.50M
Cash$61.32M
Debt$692.0K
Short InterestN/A
🏛 Institutional Holdings
QoQ: ↑ 42.7% shares (2025Q4 vs prior)
37 institutional holders · 42.53M shares
#1
ADAR1 Capital Management, LLC
11.22M shares
#2
JANUS HENDERSON GROUP PLC
5.86M shares
#3
ADAGE CAPITAL PARTNERS GP, L.L.C.
5.33M shares
+ 17 more holders Sign up free to view →
📉 Short Interest
Short Interest2.87M
Days to Cover12.3
% of Float9.1%
FINRA data as of May 15, 2026
📁 Recent SEC Activity
xbrl
XBRL WARRANT
Dec 31, 2019
xbrl
XBRL CONVERTIBLE
Dec 31, 2018
S-3
SHELF
Apr 07, 2026
EFFECT
EFFECT
Mar 25, 2026
4
INSIDER TRANSACTION
Mar 16, 2026
Full SEC filing analysis available with free account →
📰 Recent News
No recent news
🔬 More Research for EQ
📊 EQ FDA Catalyst Timeline & Biotech Grade — BiotechSigns
📡 EQ Signal Convergence & Dark Pool Activity — StonkWhisper
Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.